These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 5855233)
1. Genetically determined side-effects of drugs. Liddell J Anglo Ger Med Rev; 1965 Nov; 3(1):13-24. PubMed ID: 5855233 [No Abstract] [Full Text] [Related]
2. [In case of risks and side effects: ask your genes, too]. Möritz A Med Monatsschr Pharm; 2007 May; 30(5):179-83. PubMed ID: 17526394 [TBL] [Abstract][Full Text] [Related]
3. [Genetic causes for the variability of effects and side effects of drugs]. Roots I Internist (Berl); 1982 Nov; 23(11):601-9. PubMed ID: 6759450 [No Abstract] [Full Text] [Related]
4. [Comparative pharmacogenetics of humans and mammals. II]. Jörgensen G Med Welt; 1966 Jan; 2():84-91. PubMed ID: 5335586 [No Abstract] [Full Text] [Related]
5. Drugs and heredity. Pharmacogenetics--the study of heritable variations in drug response. Schimke RN J Kans Med Soc; 1969 Mar; 70(3):146-50. PubMed ID: 5773193 [No Abstract] [Full Text] [Related]
8. Otologic side effects of drugs. Lee CA; Mistry D; Uppal S; Coatesworth AP J Laryngol Otol; 2005 Apr; 119(4):267-71. PubMed ID: 15949078 [TBL] [Abstract][Full Text] [Related]
9. Genomics and personalized medicine. Meadows M FDA Consum; 2005; 39(6):12-7. PubMed ID: 16669113 [No Abstract] [Full Text] [Related]
10. [A literature review of adverse drug reaction reports. Adverse drug effects can have genetical background]. Rane A Lakartidningen; 2002 May; 99(20):2266-7. PubMed ID: 12082942 [No Abstract] [Full Text] [Related]
11. [Pharmacogenetics from the aspect of the Coordinating Group for Pharmacogenetics of OECD]. Brdicka R Cas Lek Cesk; 2005; 144(2):134-5. PubMed ID: 15807303 [No Abstract] [Full Text] [Related]
12. Nephropharmacology: drugs and the kidney. Atkinson AJ; Huang SM Clin Pharmacol Ther; 2009 Nov; 86(5):453-6. PubMed ID: 19844216 [No Abstract] [Full Text] [Related]
13. Personalized medicine: challenges in assessing and capturing value in the commercial environment. Ferrara J Expert Rev Mol Diagn; 2006 Mar; 6(2):129-31. PubMed ID: 16512770 [No Abstract] [Full Text] [Related]
14. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Spielberg SP Fed Proc; 1984 May; 43(8):2308-13. PubMed ID: 6714438 [TBL] [Abstract][Full Text] [Related]
16. [Side effects of drugs leading to hospitalization in emergency medical departments. How good is the reporting system?]. Laake K; Kramer S; Nordal A; Borchgrevink CF Tidsskr Nor Laegeforen; 1985 Sep; 105(26):1792-5. PubMed ID: 4060128 [No Abstract] [Full Text] [Related]
17. [Difficulties and bias in attributing side effects to drugs]. Weintraub M Nouv Presse Med; 1982 Oct; 11(40):3003-5. PubMed ID: 7145685 [TBL] [Abstract][Full Text] [Related]
18. Reimbursing side effects of pharmaceutical drugs--a Scandinavian speciality. Perman E J Insur Med; 1997; 29(1):36-8. PubMed ID: 10173025 [TBL] [Abstract][Full Text] [Related]
20. [The role of genetically determined acetylation of drugs and xenobiotics in pathogenesis of neoplastic diseases]. Niewiński P; Orzechowska-Juzwenko K Postepy Hig Med Dosw; 1996; 50(2):131-43. PubMed ID: 8848422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]